Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results.
Resource Type
Academic Journal
Authors
Rai S; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka-Sayama. rai@med.kindai.ac.jp.; Kim WS; Division of Hematology Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul.; Ando K; Hematology and Oncology, Tokai University Hospital, Isehara.; Choi I; Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka.; Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo.; Tsukamoto N; Oncology Center, Gunma University Hospital, Maebashi.; Maruyama D; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.; Tsukasaki K; Hematology, International Medical Center, Saitama Medical University, Saitama.; Kuroda J; Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto.; Ando J; Department of Hematology, Juntendo University School of Medicine, Tokyo.; Hidaka M; Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto.; Koh Y; Internal Medicine, Seoul National University Hospital, Seoul.; Kato H; Hematology and Oncology, Osaka University Graduate School of Medicine, Suita.; Uchida T; Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya.; Yang DH; Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National Medical School, Gwangju.; Ishitsuka K; Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima.; Ishizawa K; Third Internal Medicine, Yamagata University Hospital, Yamagata.; Kim JS; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul.; Lee HG; Hematology and Oncology, Konkuk University Medical Center, Seoul.; Minami H; Medical Oncology/Hematology, Kobe University Hospital, Kobe.; Eom HS; Center for Hematologic Malignancy, National Cancer Center, Goyang-si.; Kurosawa M; Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo.; Lee JH; Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon.; Lee JS; Division of Hematology-Oncology, Seoul National University Bundang Hospital, Gyeonggi.; Lee WS; Internal Medicine, Inje University Busan Paik Hospital, Busan.; Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya.; Shindo T; Hematology and Oncology, Kyoto University Hospital, Kyoto.; Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul.; Yoshida S; Hematology, National Hospital Organization Nagasaki Medical Center, Omura.; Gillings M; HUYABIO International, San Diego, CA.; Onogi H; Huya Japan GK, Tokyo.; Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo.
Source
Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE